My ePortfolio Register   

Updates in melanoma: Treating BRAF and brain metastases

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.06.17
Views: 2440
Rating:

Prof Georgina Long - University of Sydney, Sydney, Australia

Prof Long speaks with ecancer at ASCO 2017 about 5 year survival updates for BRAF melanoma patients treated with trametinib and dabrafenib.

She also reports on results from a trial of treating brain metastases with combined PD-1 and CTLA-4, reaching a PFS at 6 months of 47%.

Prof Long comments on the addition of radiotherapy to treat brain metastases, noting the work of Dr Ines Silva in establishing radionecrosis.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence